Literature DB >> 10966169

Assessment of peripheral blood lymphocyte subsets in idiopathic myelofibrosis.

F Cervantes1, J C Hernández-Boluda, N Villamor, A Serra, E Montserrat.   

Abstract

The objective of this study was to contribute to a better characterization of the immunological profile of idiopathic myelofibrosis (IM) at presentation by analysing the blood lymphocyte subsets and their possible correlations with other disease features. Absolute blood lymphocytes and lymphocyte subsets were assessed in 31 IM patients, compared with those from 34 healthy individuals, and correlated with the patients' main clinical, hematological and bone marrow histologic features. The mean lymphocyte count of the IM patients was 1.1 (SD 0.6) x 10(9)/L, versus 1.6 (SD 0.49) x 10(9)/L in controls (p = 0.0006), with 24 of the 31 patients (77.4%) showing lymphocytopenia (< 1.5 x 10(9)/L). IM patients had significantly lower counts of CD3, CD4, CD8, and CD3 -/ CD56+ cells, and significantly higher CD3 +/CD56 + lymphocyte counts. Although no significant differences were found between patients and controls with regard to CD19+/CD5+ cell counts, increased CD5 + B-cell lymphocytes were observed in three IM patients. In one of the latter patients, Ig gene rearrangement analysis of the heavy chain gene demonstrated such a subpopulation to be clonal, but the patient did not develop features of chronic lymphoid leukemia during a 5-yr follow-up. No correlation was found between the patients' blood lymphocyte counts and other disease features. We conclude that most IM patients have absolute lymphopenia, decreased T cells and increased cytotoxic T cells at diagnosis, and 10% of them show an increased CD5 + B-cell subpopulation.

Entities:  

Mesh:

Year:  2000        PMID: 10966169     DOI: 10.1034/j.1600-0609.2000.90262.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  9 in total

1.  Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response.

Authors:  Morten Orebo Holmström; Caroline Hasselbalch Riley; Vibe Skov; Inge Marie Svane; Hans Carl Hasselbalch; Mads Hald Andersen
Journal:  Oncoimmunology       Date:  2018-02-27       Impact factor: 8.110

Review 2.  An immune dysregulation in MPN.

Authors:  Giovanni Barosi
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

3.  Fatal ruxolitinib-related JC virus meningitis.

Authors:  Begoña Ballesta; Héctor González; Vicente Martín; Juan J Ballesta
Journal:  J Neurovirol       Date:  2017-08-08       Impact factor: 2.643

4.  Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression.

Authors:  Ana Micaela Carnaz Simões; Morten Orebo Holmström; Pia Aehnlich; Anne Rahbech; Aneta Radziwon-Balicka; Carlos Zamora; Tobias Wirenfeldt Klausen; Vibe Skov; Lasse Kjær; Christina Ellervik; Daniel El Fassi; Silvia Vidal; Hans Carl Hasselbalch; Mads Hald Andersen; Per Thor Straten
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

5.  Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis.

Authors:  Marko Lucijanic; Ivo Veletic; Dario Rahelic; Vlatko Pejsa; David Cicic; Marko Skelin; Ana Livun; Katarina Marija Tupek; Tajana Stoos-Veic; Tomo Lucijanic; Ana Maglicic; Rajko Kusec
Journal:  Wien Klin Wochenschr       Date:  2018-01-25       Impact factor: 1.704

6.  Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics.

Authors:  Gabriele Todisco; Taghi Manshouri; Srdan Verstovsek; Lucia Masarova; Sherry A Pierce; Michael J Keating; Zeev Estrov
Journal:  Leuk Lymphoma       Date:  2015-10-19

7.  Expression of CD markers in JAK2V617F positive myeloproliferative neoplasms: Prognostic significance.

Authors:  Saeid Shahrabi; Ali Ehsanpour; Somayyeh Heidary; Mohammad Shahjahani; Masumeh Maleki Behzad
Journal:  Oncol Rev       Date:  2018-10-02

8.  Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype.

Authors:  Vitor Leonardo Bassan; Gabriel Dessotti Barretto; Felipe Campos de Almeida; Patrícia Vianna Bonini Palma; Larissa Sarri Binelli; João Paulo Lettieri da Silva; Caroline Fontanari; Ricardo Cardoso Castro; Lorena Lôbo de Figueiredo Pontes; Fabiani Gai Frantz; Fabíola Attié de Castro
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

9.  The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis.

Authors:  Martina Barone; Lucia Catani; Francesca Ricci; Marco Romano; Dorian Forte; Giuseppe Auteri; Daniela Bartoletti; Emanuela Ottaviani; Pier Luigi Tazzari; Nicola Vianelli; Michele Cavo; Francesca Palandri
Journal:  Oncoimmunology       Date:  2020-06-23       Impact factor: 8.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.